Share
     
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
11:00
TUAD0101
How do HIV cure trial researchers respond to an embedded social science study?
Holly Peay, 1RTI International, United States
Abstract
11:15
TUAD0102
Bringing good participatory practice into action: Considerations and challenges from a sponsor perspective
Karen Buleza, Janssen Research and Development, United States
Abstract
Slides
11:30
TUAD0103
Getting from good participatory practice to good trial outcomes for everyone: How stakeholders believe GPP works (or not)
Kathleen MacQueen, FHI 360, United States
Abstract
11:45
TUAD0104
The game-changing nature of early and ongoing community engagement in HIV prevention efficacy trials: The AMP studies' experience (HVTN 703/HPTN 081 & HVTN 704/HPTN 085)
Michele Andrasik, Fred Hutch, United States
Abstract
Slides
12:00
TUAD0106
Engaging youth as long-acting HIV prevention product co-researchers in the iPrevent study in Cape Town, South Africa
Miriam Hartmann, RTI International, United States
Abstract
Slides
AUTHOR
SUMMARY
HIGHLIGHTS
CRITICAL ASSESSMENT